HONOLULU, Nov. 10, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) Chairman, President and Chief Executive Officer John C. Lechleiter, Ph.D., today said new trade agreements, effective public policies, and continued collaboration to bring innovation to patients are needed to assure improved health and economic prosperity in the Asia-Pacific region.
Lechleiter's comments come as the United States hosts the Asia-Pacific Economic Cooperation (APEC) CEO Summit in Honolulu. The 21 members economies of APEC include one-third of the world's population and 55 percent of the world's GDP. Nearly 60 percent of U.S. exports go to APEC economies, and seven of America's top 15 trading partners are in APEC.
"I am excited to attend this summit because it is such a positive vehicle for U.S. business and policy engagement with these important nations," said Lechleiter. "As a leader of a major U.S. biopharmaceutical company, I am encouraged by APEC leaders' increasing focus on improving health care as a vital component of their plan to reinvigorate economic growth in the APEC region."
Lechleiter will participate in the summit's opening panel discussion with Prime Minister Lee Hsien Loong of Singapore and Dennis Nally, CEO of PwC, which will examine how companies and policymakers are transforming their expectations of the future as the Asia-Pacific region changes.
In connection with his role in the panel discussion, Lechleiter outlined three major areas of opportunity for improved health and economic growth in the region:
Trans-Pacific Partnership (TPP)
In the past, APEC has played an integral role in the trade debate, developing the structural framework for agreements throughout the region. One such agreement currently being negotiated is the Trans-Pacific Partnership (TPP), which was announced at the APEC Leaders meeting
|SOURCE Eli Lilly and Company|
Copyright©2010 PR Newswire.
All rights reserved